Treatment of Lactic Acidosis
The primary treatment of lactic acidosis is identifying and aggressively treating the underlying cause—sodium bicarbonate should NOT be used for pH ≥7.15 as it does not improve outcomes and may cause harm. 1
Immediate Management Priorities
1. Identify and Treat the Underlying Cause
This is the cornerstone of management and takes absolute priority over all other interventions. 1
For Type A Lactic Acidosis (Tissue Hypoxia):
- Restore tissue perfusion with aggressive fluid resuscitation (15-20 mL/kg/h isotonic saline initially) if shock is present 1
- Treat sepsis aggressively with source control, antibiotics within 3 hours, and hemodynamic support per Surviving Sepsis Campaign protocols 1
- Consider vasopressors (norepinephrine first-line, epinephrine second-line) if hypotension persists despite fluid resuscitation 2
For Medication-Induced Lactic Acidosis:
- Discontinue offending medications immediately 1:
2. Supportive Care Measures
Hemodialysis for Metformin-Associated Lactic Acidosis (MALA):
- Prompt hemodialysis is recommended for suspected or confirmed MALA 3
- Metformin is dialyzable with clearance up to 170 mL/min under good hemodynamic conditions 3
- Hemodialysis often results in reversal of symptoms and recovery 3
- Continuous renal replacement therapy (CRRT) is preferred in hemodynamically unstable patients as it corrects acidosis without risk of hypernatremia or fluid overload 4, 5
Thiamine Supplementation:
- Consider thiamine to address pyruvate dehydrogenase dysfunction 1
The Bicarbonate Controversy: When NOT to Use It
The Surviving Sepsis Campaign explicitly recommends AGAINST using sodium bicarbonate to improve hemodynamics or reduce vasopressor requirements in hypoperfusion-induced lactic acidemia with pH ≥7.15. 1
Why bicarbonate is harmful:
- Does not improve hemodynamics or cardiovascular function 1, 6
- May increase lactate production 1
- Causes hypernatremia and volume overload 1
- Generates CO₂ 1
- Has never been shown to improve survival 1, 6
Exception: Bicarbonate may be considered only when pH <7.15 in the setting of severe acidosis with catecholamine receptor resistance-induced hypotension 2
Special Clinical Scenarios
D-Lactic Acidosis (Short Bowel Syndrome)
- Restrict mono/oligosaccharides 1
- Encourage polysaccharides (starch) 1
- Give thiamine supplements 1
- Administer broad-spectrum antibiotics 1
Metformin-Associated Lactic Acidosis
Risk factors to recognize:
- Renal impairment (eGFR <30 mL/min/1.73 m²) 3
- Acute kidney injury from any cause 1
- Sepsis or systemic infection with hemodynamic instability 1
- Hypoxic states 1
- Severe illness, vomiting, or dehydration 2
Management algorithm:
- Discontinue metformin immediately 3
- Institute general supportive measures promptly in hospital setting 3
- Initiate prompt hemodialysis or CRRT to correct acidosis and remove accumulated metformin 3, 4, 5
HIV Patients on NRTIs
- Discontinue NRTIs immediately (especially stavudine and didanosine) 1
- High mortality without intervention 1
Monitoring and Laboratory Targets
Key laboratory values:
- Lactate >5 mmol/L with anion gap acidosis indicates metformin-associated lactic acidosis 3
- Metformin plasma levels generally >5 mcg/mL in MALA 3
- pH <7.3 with lactate >2 mmol/L confirms lactic acidosis 1
Serial monitoring:
- Repeat lactate within 6 hours to evaluate trend 1
- Monitor electrolytes closely during renal replacement therapy 1
Common Pitfalls to Avoid
- DO NOT delay treatment while waiting for lactate levels—treat the underlying cause immediately 1
- DO NOT use sodium bicarbonate unless pH <7.15 2, 1
- DO NOT continue metformin in any patient with acute illness, sepsis, or renal dysfunction 3
- DO NOT ignore subtle early symptoms (nonspecific GI symptoms, dyspnea, weakness, myalgias) that often precede severe acidosis 1
- DO NOT delay hemodialysis in suspected MALA—it is the definitive treatment 3, 4, 5
Patient Education
Educate patients and families about symptoms of lactic acidosis: malaise, myalgias, abdominal pain, respiratory distress, increased somnolence 3. Instruct them to discontinue metformin and report symptoms immediately to their healthcare provider 3.